BRAF and melanoma: Cutaneous melanoma samples with HRD had significantly higher prevalence of NF1 mutation (36.06% v 18.5%, P < .001) and significantly lower prevalence of V-RAF murine sarcoma viral oncogene homolog B (BRAF) mutation (48.0% v 37.03%, P < .01; Fig 1C).